Mechanisms of pain sensitization and the treatments
Hiroshima Conference on Education and Science in Dentistry, 2006 : the 40th Anniversary of Hiroshima University Faculty of Dentistry
Page 87-94
published_at 2006-01-08
アクセス数 : 1551 件
ダウンロード数 : 92 件
今月のアクセス数 : 8 件
今月のダウンロード数 : 0 件
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00000100
File |
Symp-Edu-Sci_87-94.pdf
2.62 MB
種類 :
fulltext
|
Title ( eng ) |
Mechanisms of pain sensitization and the treatments
|
Creator |
Dohi Toshihiro
Morita K.
Abdin M.J.
Kitayama T.
Motoyama N.
Zohn R.
|
Source Title |
Hiroshima Conference on Education and Science in Dentistry, 2006 : the 40th Anniversary of Hiroshima University Faculty of Dentistry
|
Start Page | 87 |
End Page | 94 |
Abstract |
Hyperalgesia and allodynia, major symptoms of neuropathic pain can results after nerve injury or chronic inflammation. Trigeminal neuropathic pain resulting from alterations in peripheral and central noxious transmission systems often produced after nerve injury by pulpectomy or tooth-extraction or from temporomandibular joint inflammation. Neuropathic also occurs in some disease state, diabetic peripheral neuropathy, post-herpetic neuropathy and trigeminal neuralgia. Allodynia is characterized by long lasting pain evoked by essentially non-painful stimuli such as just light touch and tolerance to medication with conventional analgesics.Neuropathic pain is probably not a result of a single pathological mechanism, but the final product of an altered peripheral and central processing. Recent advances in pain research revealed that many factors derived from neurons and also non-neuronal neighboring residents participate in the initiation, development and maintenance. Among them, lipid mediators such as prostaglandins, lysophosphatidic acid and platelet-activating factor are recently found to play conspicuous roles for development of allodynia and hyperalgesia in spinal cord. Further advance by using cellular biological and molecular techniques would dig into the mechanisms underlying neuropathic pain and illustrate the new strategy and target candidate for drug development.There are also needs for tools and methods to assess neuropathic pain, common guidelines on classification, diagnosis and management, and evidence-based approach to the treatment of neuropathic pain.
|
Keywords |
neuropathic pain
allodynia
hyperalgesia
prostaglandin
platelet-activating factor
glutamate
ATP
cyclic GMP
|
NDC |
Medical sciences [ 490 ]
|
Language |
eng
|
Resource Type | conference paper |
Date of Issued | 2006-01-08 |
Publish Type | Version of Record |
Access Rights | open access |
Source Identifier |
[URI] http://ir.lib.hiroshima-u.ac.jp/meta-bin/mt-pdetail.cgi?smode=1&edm=0&tlang=1&cd=00014842
isPartOf
|